Quarterly report pursuant to sections 13 or 15(d)

Stock-Based Compensation (Tables)

v2.4.0.8
Stock-Based Compensation (Tables)
 6 Months Ended
Dec. 31, 2013
Share-Based Compensation [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock option activity is as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Options
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2012
 
 
-
 
$
-
 
 
-
 
Granted
 
 
9,050,000
 
$
0.75
 
 
 
 
Outstanding, June 30, 2013
 
 
9,050,000
 
$
0.75
 
 
4.6
 
Outstanding, December 31, 2013
 
 
9,050,000
 
$
0.75
 
 
4.1
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2013
 
 
6,768,058
 
$
0.75
 
 
4.1
 
Schedule Of Warrants Issued To Agents Activity [Table Text Block]
AntriaBio issued warrants to agents and note holders in conjunction with the closing of its convertible notes payable as follows: 
 
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Warrants
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2012
 
 
-
 
$
-
 
 
-
 
Warrants issued to placement agents
 
 
248,542
 
$
0.33
 
 
 
 
Warrants issued to placement agent
 
 
1,400,000
 
$
0.25
 
 
 
 
Warrants issued to placement agent
 
 
110,000
 
$
0.85
 
 
 
 
Outstanding, June 30, 2013
 
 
1,758,542
 
$
0.30
 
 
4.1
 
Warrants issued to note holders
 
 
710,000
 
$
0.32
 
 
 
 
Outstanding, December 31, 2013
 
 
2,468,542
 
$
0.30
 
 
3.4
 
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
Significant assumptions were as follows:
 
Expected volatility
 
97% - 111%
 
Risk free interest rate
 
0.78% - 1.41%
 
Warrant term (years)
 
3 - 5
 
Dividend yield
 
0%